Table 3.
Comparative analysis of short-term outcomes and three-year recurrence from unmatched and propensity-matched groups.
| Before matching |
After matching |
|||||
|---|---|---|---|---|---|---|
| NCRS (n=301) (%) | NCS (n=307) (%) | P value | NCRS (n=221) (%) | NCS (n=221) (%) | P value | |
| 30-day mortality | 9 (3) | 5 (1.6) | 0.263 | 9 (4.1) | 3 (1.4) | 0.140 |
| 90-day mortality | 15 (5) | 7 (2.3) | 0.074 | 13 (5.9) | 5 (2.3) | 0.090 |
| Anastomotic leak a | 61 (20.4) | 15 (5.6) | <0.001 | 51 (23.1) | 13 (6.8) | <0.001 |
| Pulmonary complications a | 135 (44.9) | 103 (38.9) | 0.15 | 101 (45.7) | 72 (38.3) | 0.134 |
| Cardiac complications a | 58 (19.3) | 56 (21.1) | 0.581 | 43 (19.5) | 36 (19.1) | >0.999 |
| Chyle leak a | 22 (7.3) | 24 (9.1) | 0.448 | 17 (7.7) | 13 (6.9) | 0.850 |
| Reoperation | 27 (9.1) | 20 (6.5) | 0.108 | 22 (10.2) | 14 (6.5) | 0.050 |
| Recurrence | ||||||
| Locoregional | 15 (5.0) | 19 (6.2) | 0.542 | 10 (4.5) | 14 (6.3) | 0.660 |
| Distant | 73 (24.3) | 70 (22.8) | 56 (25.3) | 60 (27.1) | ||
| Mixed | 30 (10.0) | 22 (7.2) | 19 (8.6) | 14 (6.3) | ||
NCRS, neoadjuvant chemoradiotherapy and surgery; NCS, neoadjuvant chemotherapy and surgery.
a
Missing data.